Literature DB >> 6969593

Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens.

D A Bell, P J Maddison.   

Abstract

A search for anti-Ro or anti-nRNP antibodies by precipitin analysis among a population of 64 patients with systemic lupus erythematosus (SLE) or mixed connective tissue disease was undertaken. The 25% of SLE patients with anti-Ro did not have any distinct clinical features, compared to patients without anti-Ro or to anti-nRNP patients with SLE or mixed connective tissue disease. However, these patients did have a significantly greater frequency of rheumatoid factor (80%). Most importantly however, patients with anti-Ro had a significantly increased frequency of HLA-B8 (81%) and HLA-DRw3 (100%) compared to patients with anti-nRNP (B8--29%; DRw3--33%) or SLE patients without such antibodies (B8--41%; DRw3--25%). These data suggest the existence of a specific immune response gene for Ro close to the D region of the major histocompatibility complex.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969593     DOI: 10.1002/art.1780231107

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  35 in total

1.  Antibodies to T- and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus.

Authors:  E C De Mendonca Neto; A Kumar; N A Shadick; A M Michon; P Matsudaira; R B Eaton; P Kumar; P H Schur
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

2.  HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus.

Authors:  H A Stephens; N J McHugh; P J Maddison; D A Isenberg; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Neonatal lupus erythematosus.

Authors:  D A Bell
Journal:  Can Med Assoc J       Date:  1983-10-15       Impact factor: 8.262

Review 4.  Significance of the Ro antigen system.

Authors:  M Reichlin
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

5.  The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group.

Authors:  K Hartung; H Ehrfeld; H J Lakomek; R Coldewey; B Lang; F Krapf; R Müller; D Schendel; H Deicher; H P Seelig
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

6.  Immunogenetic markers in rheumatic diseases.

Authors:  L Martin; M J Fritzler
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

Review 7.  Systemic lupus erythematosus.

Authors:  G R Hughes
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

8.  Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus.

Authors:  P Ruuska; R Hämeenkorpi; S Forsberg; H Julkunen; R Mäkitalo; J Ilonen; A Tiilikainen
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

9.  Immunoglobulin allotypes are not associated with HLA-antigens, autoantibodies and clinical symptoms in systemic lupus erythematosus. Members of the SLE Study Group.

Authors:  K Hartung; R Coldewey; E Röther; K Pirner; C Specker; D Schendel; W Stangel; S Stannat-Kiessling; G G de Lange
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

10.  Antibodies to Sm and SS-A demonstrated by enzyme immunoassay. Correlation to clinical manifestations and disease activity in patients with systemic lupus erythematosus.

Authors:  M Gripenberg; A M Teppo; C Friman
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.